Expression of Opa interacting protein 5 in pancreatic cancer and its effect on the proliferation of PANC-1 cells

Abstract

Abstract: Objective To explore the expression of OPA interacting protein 5 (OIP5) in pancreatic cancer and its effect on the proliferation of PANC-1 cells. Methods The expression of OIP5 in pancreatic cancer and adjacent tissues was evaluated by database; the expression of OIP5 mRNA and protein in human pancreatic cancer cell lines like MIAPaCa-2, PANC-1, KP-3 and BxPC-3 was detected by real-time quantitative PCR (RT-qPCR) and Western blot, respectively; the expression of OIP5 gene silencing plasmid (pGCSIL-shOIP5)and control plasmid(pGCSIL-shCtrl)were observed, respectively infected with PANC-1 cells, then divided into OIP5 gene silencing group and shctrl control group. 5 days later, RT-qPCR and Western blot were used to detect slow virus knockdown efficiency, and flow cytometry was used to detect cell apoptosis. MTT and cell count were carried out in OIP5 gene silencing group and shctrl control group for 5 consecutive days. OIP5 gene silencing group and shctrl control group were incubated for 10 days to form colonies, then Giemsa staining was used to count total number of sets. Results The expression of OIP5 mRNA in pancreatic cancer was significantly higher than that in normal pancreatic tissue(P＜0.05), and the overall survival rate in patients with high expression of OIP5 was significantly lower than that in patients with low expression of OIP5 (P＜ 0.05), and the disease-free survival rate was also significantly lower (P＜0.05); the expression of OIP5 was higher in MIAPaCa-2, PANC-1 and KP-3, but lower in BXPC-3 cell line; the results of MTT showed that OIP5 was silenced in the 4th day. The proliferation rate of PANC-1 cells was significantly decreased on the 4th and the 5th day (P＜0.01); the number of cell colonies (9 on average) after OIP5 silencing was significantly lower than that in shctrl control group (40 on average) (P＜0.01); the apoptosis rate of PANC-1 cells after OIP5 silencing was 8.3% and 4.5% higher than that of shctrl (P＜0.01). Conclusions OIP5 is highly expressed in pancreatic cancer cell lines. OIP5 gene can regulate the proliferation, apoptosis and clonal formation of PANC-1 cells, suggesting that OIP5 may play a role as a oncogene in the pathogenesis of pancreatic cancer, thus providing a potential biomarker for targeted treatment of pancreatic cancer.

Key words: Opa interacting protein 5, pancreatic cancer, proliferation, apoptosis

CLC Number:

R735.9

ZHOU Hong-ming, TANG Xiao-niu, GUO Wei, LYU Ye-chao, JIANG Yu-xin. Expression of Opa interacting protein 5 in pancreatic cancer and its effect on the proliferation of PANC-1 cells[J]. Basic & Clinical Medicine, 2020, 40(6): 803-810.

References

[1]Kamisawa T,Wood LD,Itoi T,et al.Pancreatic Cancer[J]. Lancet, 2016, 388:73-85.
[2]魏超,张晓,高杰.长链非编码RNA与mRNA在胰腺癌中的差异表达及其预后价值[J].癌变·畸变·突变,2019,31:119-126+132.
[3]Chen W, Zheng R, Baade PD,et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66:115-132.
[4]Chen W,Sun K,Zheng R,et al. Cancer incidence and mortalityin China,2014[J]. Chin J Cancer Res,2018,30: 1-12.
[5]Inoue K, Maeda N, Mori T,et al. Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity[J]. PLoS One 2014; 9: e87661. doi: 10.1371/journal.pone.0087661.
[6]He X, Ding X, Wen D,et al. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5[J]. Pathol Res Pract, 2017,213: 1059-1066.
[7]Wang J, Liu X, Dou Z, et al. Mitotic regulator Mis18beta interacts with and specifies the centromeric assembly of molecular chaperone holliday junction recognition protein (HJURP)[J]. J Biol Chem, 2014, 289: 8326-8336.
[8]KiM TW,Lee SJ,Park YJ,et al. Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer[J]. Tumour Biol, 2017, 39: 1010428317733985. doi: 10.1177/1010428317733985.
[9]Li HC, Chen YF, Feng W,et al.Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway[J]. Gene, 2017, 603: 1-8.
[10]Zheng YQ,Cui YR,Yang S,et al.Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal[J].Eur Rev Med Pharmacol Sci,2019, 23: 613-621.
[11]Gong M, Xu Y, Dong W, et al. Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma[J]. Acta Histochemica, 2013, 115: 810-815.
[12]Chun HK, Chung KS, Kim HC, et al. OIP5 is a highly expressed potential therapeutic target for colorectal and gastric cancers[J]. BMB Rep, 2010, 43: 349-354.
[13]Nakamura Y, Tanaka F, Nagahara H, et al. Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer[J]. Ann Surg Oncol, 2007, 14: 885-892.
[14]Yazarloo F, Shirkoohi R, Mobasheri MB, et al. Expres-sion analysis of four testis-specific genes AURKC, OIP5, PIWIL2 and TAF7L in acute myeloid leukemia: a gender-dependent expression pattern[J]. Med Oncol, 2013, 30: 368.doi: 10.1007/s12032-012-0368-8.
[15]Koinuma J, Akiyama H, Fujita M, et al. Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis[J]. Cancer Sci, 2012, 103: 577-586.
[16]Li H, Zhang J, Lee MJ, et al. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and beta-catenin signaling pathways[J]. Oncotarget, 2017, 8: 18129-18144.
[17]Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interac-tive analyses[J]. Nucleic Acids Res, 2017, 45: W98-W102.
[18]Lois C, Hong EJ, Pease S, et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors[J]. Science, 2002, 295: 868-872.
[19]Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR[J]. Nucleic Acids Res, 2001, 29: 2002-2007.
[20]Williams JM, Chen GC, Zhu L, et al. Using the yeast two-hybrid system to identify human epithelial cell proteins that bind gonococcal Opa proteins: intracellular gonococci bind pyruvate kinase via their Opa proteins and require host pyruvate for growth[J]. Mol Microbiol, 1998, 27: 171-186.
[21]Gjerstorff MF, Andersen MH, Ditzel HJ. Oncogenic cancer/testis antigens: prime candidates for immunotherapy[J]. Oncotarget, 2015, 6: 15772-15787.
[22]Fu J, Luo B, Guo WW, et al. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro[J]. Int J Clin Exp Pathol, 2015, 8: 7786-7797.
[23]Hu GW, Wu L, Kuang W, et al. Knockdown of linc-OIP5 inhibits proliferation and migration of glioma cells through down-regulation of YAP-NOTCH signaling pathway[J]. Gene, 2017, 610:24-31.
[24]He X, Hou J, Ping J, et al. Opa interacting protein 5 acts as an oncogene in bladder cancer[J]. J Cancer Res Clin Oncol, 2017,143:2221-2233.
[25]He X, Ding X, Wen D, et al. Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5[J]. Pathol Res Pract, 2017, 213: 1059-1066.
[26]Li HC, Chen YF, Feng W, et al. Loss of the Opa interacting protein 5 inhibits breast cancer proliferation through miR-139-5p/NOTCH1 pathway[J]. Gene, 2017, 603:1-8.
[27]Mobasheri MB, Shirkoohi R, Modarressi MH. Cancer/testis OIP5 and TAF7L genes are up-regulated in breast cancer[J]. Asian Pac J Cancer Prev, 2015, 16: 4623-4628.
[28]Inoue K, Maeda N, Mori T, et al. Possible involvement of Opa-interacting protein 5 in adipose proliferation and obesity[J]. PLoS One, 2014, 9: e87661.doi: 10.1371/journal.pone.0087661.
[29]Kim TW, Lee SJ, Park YJ, et al. Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer[J]. Tumour Biol, 2017, 39: 1010428317733985. doi: 10.1177/1010428317733985.